The Innovative Medicins Initiative (IMI) launched its 8th call for proposals.Topics included under the IMI programme “Combating Antibiotic Resistance: New Drugs for Bad Bugs” are:
- Topic 1C: Innovative Trial Design & Clinical Development
- Topic 3: Discovery and development of new drugs combating Gram – negative infections
Dealine for submitting a proposal is 19 March 2013.
About the Innovative Medicins Initiative:
The Innovative Medicines Initiative (IMI) is Europe’s largest public-private initiative aiming to speed up the development of better and safer medicines for patients. IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe. IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.